Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Zevia PBC (ZVIA)
NYSEConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-11-05
$1.36+13.33%
Close 2026-11-05 · 1-day change
NYSEConsumer StaplesBeverages - Non-alcoholicSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for ZVIA yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA loss narrows to $2M-$4M in 2026 | A primary condition in Zevia PBC's published investment case. The stated target is Adjusted EBITDA loss between -$4M and -$2M. | Intact | Loss exceeds -$4M in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making business with a growth-and-profitability reset underway, rather than an established durable compounder. The long-term thesis is in a watch state: company momentum improved, but recent financial performance remains well below its industry cohort.
The valuation evidence points to ZVIA being cheap versus peers, while the expectations gap is slightly negative and the model has medium confidence. The priced-in assessment is tagged justified, with low fragility, so the evidence does not suggest that expectations are unusually stretched.
Near term, sales have increased year over year, but the latest quarter was only modestly higher, and operating loss widened from the first to the second quarter of 2026. Productivity Initiative savings reduced selling expenses, but management’s broader profitability progress remains limited; full-year sales guidance is $170 million to $175 million. A guidance cut is a key near-term risk, while the reported miss risk is described as low despite the company’s smaller size and history of a deep miss.
Over the next 1 to 3 years, the thesis hinges on whether management can turn its strategic reset into sustained sales growth and lower operating losses. Near term, a guidance cut or further weakening in jobs data could weigh on the setup, while continued strong results from sector bellwethers could support sector momentum. Recent divestiture and preferred-stock events add context, but the evidence provided does not detail their business effects.
ZVIA remains a high-risk, loss-making watch case: peer-relative cheapness and some cost savings are countered by weak results and limited progress toward profitability. The multi-year view hinges on execution, with medium confidence. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Gross profit rose from $18M to $22M last quarter. |
| Intact |
| Gross profit falls below $18M next quarter |
Gross profit: $22.441M FY2026-Q3; GAAP. Published target: Gross profit increases to at least $22.29M next quarter. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 4, 202622,441,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches $170M-$175M in 2026 | A primary condition in Zevia PBC's published investment case. The stated target is >= $170M and <= $175M. | Intact | Revenue falls below $162M in FY26 | Revenue: $48.343M FY2026-Q3; GAAP. Published target: >= $170M and <= $175M. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 202648,343,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.11 → $-0.07 · observed estimates
$0.18B → $0.18B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-07-25 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-07-26 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-07-27 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-07-28 | $-0.07 | $183,802,137 | 3 / 4 |
| 2026-07-29 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-07-30 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-07-31 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-08-01 | $-0.07 | $183,802,137 | 3 / 4 |
| 2026-08-02 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-08-03 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-08-04 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-08-05 | $-0.11 | $183,797,800 | 3 / 6 |
| 2026-08-06 | $-0.07 | $183,802,137 | 3 / 4 |
| 2026-08-08 | $-0.08 | $184,032,470 | 3 / 4 |
| 2026-08-09 | $-0.08 | $184,032,470 | 3 / 4 |
| 2026-08-10 | $-0.08 | $184,032,470 | 3 / 4 |
| 2026-08-12 | $-0.08 | $184,032,470 | 3 / 4 |
| 2026-08-13 | $-0.07 | $184,507,190 | 4 / 6 |
| 2026-08-14 | $-0.08 | $184,032,470 | 3 / 4 |
| 2026-08-15 | $-0.08 | $184,032,470 | 3 / 4 |
| 2026-08-16 | $-0.08 | $184,032,470 | 3 / 5 |
| 2026-08-17 | $-0.08 | $184,032,470 | 3 / 5 |
| 2026-08-18 | $-0.08 | $184,032,470 | 3 / 4 |
| 2026-08-19 | $-0.08 | $184,032,470 | 3 / 4 |
| 2026-08-20 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-21 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-22 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-23 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-24 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-25 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-26 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-27 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-28 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-29 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-30 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-08-31 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-01 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-02 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-03 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-04 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-05 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-06 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-07 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-08 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-09 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-10 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-11 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-12 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-13 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-14 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-15 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-16 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-17 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-18 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-19 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-20 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-21 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-22 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-23 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-24 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-25 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-26 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-27 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-28 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-29 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-09-30 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-01 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-02 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-03 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-04 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-05 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-06 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-07 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-08 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-09 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-10 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-11 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-12 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-13 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-14 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-15 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-16 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-17 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-18 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-19 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-20 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-21 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-22 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-23 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-24 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-25 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-26 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-27 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-28 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-29 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-30 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-10-31 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-11-01 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-11-02 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-11-03 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-11-04 | $-0.07 | $184,738,521 | 3 / 4 |
| 2026-11-05 | $-0.07 | $184,738,521 | 3 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 5 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.